SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-21-000050
Filing Date
2021-10-21
Accepted
2021-10-21 08:19:36
Documents
14
Period of Report
2021-10-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20211020.htm   iXBRL 8-K 43991
2 EX-99.1 ex991-cfoxnewsxrelease.htm EX-99.1 14030
6 BHC LOGO image2.jpg GRAPHIC 7860
  Complete submission text file 0000885590-21-000050.txt   216481

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20211020.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20211020_lab.xml EX-101.LAB 25096
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20211020_pre.xml EX-101.PRE 13047
7 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20211020_htm.xml XML 11466
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 211335789
SIC: 2834 Pharmaceutical Preparations